Cirugía
Departamento
Pfizer (United States)
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de Pfizer (United States) (8)
2024
-
Estimated Respiratory Syncytial Virus-Related Hospitalizations and Deaths Among Children and Adults in Spain, 2016–2019
Infectious Diseases and Therapy
2023
-
Efficacy and safety of ceftazidime/avibactam in patients with infections caused by β-lactamase-producing Gram-negative pathogens: A pooled analysis from the Phase 3 clinical trial programme
Journal of Antimicrobial Chemotherapy, Vol. 78, Núm. 11, pp. 2672-2682
-
Systematic review of ceftaroline fosamil in the management of patients with methicillin-resistant Staphylococcus aureus pneumonia
European Respiratory Review, Vol. 32, Núm. 170
2022
-
Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health System
ClinicoEconomics and Outcomes Research, Vol. 14, pp. 149-161
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2015
-
Preclinical test of dacomitinib, an irreversible EGFR inhibitor, confirms its effectiveness for glioblastoma
Molecular Cancer Therapeutics, Vol. 14, Núm. 7, pp. 1548-1558
2008
-
The efficacy and safety of tigecycline for the treatment of complicated intra-adominal infections - The European experience
Journal of Chemotherapy, Vol. 20, Núm. SUPPL. 1, pp. 12-19
1991
-
Expression and Characterization of a Basic Fibroblast Growth Factor‐Saporin Fusion Protein in Escherichia coli
Annals of the New York Academy of Sciences, Vol. 638, Núm. 1, pp. 434-437